Current views in chronic obstructive pulmonary disease pathogenesis and management.

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Genetics

Background:

• Chronic obstructive pulmonary disease (COPD) is a progressive lung disease primarily caused by environmental factors like cigarette smoking.
• Exposure to harmful particles triggers inflammatory responses, leading to irreversible respiratory damage.
• Genetic predisposition and aging also contribute to COPD development.

Purpose of the Study:

• To review recent advancements in understanding COPD pathology and pathophysiology.
• To highlight the roles of mitochondrial dysfunction and epigenetic alterations in COPD.
• To explore the potential of nanomedicine in COPD prevention and treatment.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of molecular pathways involved in COPD pathogenesis.
• Focus on mitochondrial and epigenetic variations.

Main Results:

• Mitochondrial alterations, including DNA damage, increased ROS, and disrupted autophagy/apoptosis, are implicated in COPD.
• Epigenetic modifications such as DNA methylation, histone modification, and non-coding RNA changes are associated with COPD.
• Nanomedicine presents a promising avenue for future COPD interventions.

Conclusions:

• Mitochondrial dysfunction and epigenetic alterations are critical molecular mechanisms in COPD.
• Further research into these pathways could lead to novel therapeutic strategies.
• Nanomedicine holds potential for innovative approaches to manage and treat COPD.